Supporting healthcare distributors and procurement partners across Sweden, Denmark, Norway, Finland, and Iceland with CE-certified wound dressing solutions for professional healthcare markets.
Scandinavia represents one of Europe's most advanced healthcare regions, recognised for high healthcare expenditure, evidence-based clinical practice, and strong adoption of advanced wound care products. Across the Nordic countries, ageing populations, chronic wound management, and expanding community healthcare services continue to support demand for high-quality wound dressings.
As a Wound Dressing Supplier for Scandinavia, Meghdoot Pharma supports distributors seeking CE-certified wound care products backed by consistent manufacturing and quality documentation.
Sweden has the largest wound care market in Scandinavia, valued at approximately USD 209.3 million and projected to reach USD 261.6 million by 2031, growing at a 4.57% CAGR. Wound dressings account for 63.1% of market revenue, while public procurement represents 64.5% of total spending. Purchasing is managed through Sweden's 21 regional authorities, including Region Stockholm and Region Skåne.
Denmark has one of the highest healthcare expenditures per capita in Europe. Public hospital procurement is coordinated through Amgros, while municipal purchasing is managed by SKI, creating structured framework agreements for medical devices. Healthcare providers continue to prioritise advanced wound dressings that reduce hospital stays and support home-based care.
Norway's fully state-funded healthcare system continues to support widespread adoption of advanced wound care technologies. Procurement is managed through four Regional Health Authorities and coordinated by Sykehusinnkjøp HF, while healthcare reforms continue shifting chronic wound management towards municipal and home healthcare services.
Nearly 25% of Finland's population is aged 65 years or older, creating sustained demand for chronic wound care. Procurement is managed through 21 Wellbeing Counties (Hyvinvointialueet), integrating hospitals, primary care, and long-term care under unified healthcare organisations.
Although smaller by population, Iceland imports almost 100% of its medical device requirements. Procurement is centred around LandspÃtali – The National University Hospital of Iceland and the national procurement agency RÃkiskaup, creating opportunities for international manufacturers capable of maintaining dependable supply.
COMPLETE PORTFOLIO
Our wound care portfolio is available for professional healthcare distribution throughout Scandinavia.
FEATURED EXPORT PRODUCT
Explore the Product Portfolio
Healthcare organisations across Scandinavia typically assess suppliers based on quality, regulatory compliance, and long-term supply capability.
Our export programme supports Nordic partners through:
As a Wound Dressing Supplier for Scandinavia, we support healthcare distributors, importers, and procurement partners with dependable manufacturing, structured documentation, and long-term supply programmes across the Nordic region.
The Nordic procurement landscape features highly distinct institutional frameworks, ranging from Denmark's centralized Amgros and SKI agreements and Norway's Sykehusinnkjøp HF to the localized regional networks of Sweden's 21 regions (like Region Stockholm) and Finland's 21 Wellbeing Counties (Hyvinvointialueet). Meghdoot Pharma provides full technical documentation, rigorous batch traceability, and adaptive production scheduling to help distribution partners successfully qualify for and secure these competitive public framework contracts.
Sweden represents the largest wound care market in the Nordic territory, valued at approximately USD 209.3 million and projected to reach USD 261.6 million by 2031 at a steady 4.57% CAGR. Wound dressings constitute the absolute core of this market, generating 63.1% of total revenue, with public procurement agencies driving 64.5% of all healthcare spending.
Growth across Scandinavia is heavily accelerated by a rapidly aging population—most notable in countries like Finland, where nearly 25% of citizens are aged 65 or older. This demographic shift has caused a significant rise in chronic wounds, pressure injuries, and diabetic foot ulcers, causing healthcare authorities to prioritize specialized dressings that manage complex exudate and minimize costly clinical interventions.
Both nations are actively executing structural reforms designed to shorten hospital stays by shifting chronic wound management toward municipal care, community health hubs, and home healthcare settings. Consequently, there is high institutional demand for advanced, moisture-balanced dressings that offer extended wear times, protect fragile skin, and allow home-care nurses to manage wounds efficiently.
Because Iceland relies on imports for nearly 100% of its medical device and hospital supply requirements, it presents an ideal target for established international manufacturers. Purchasing is concentrated heavily through LandspÃtali (The National University Hospital of Iceland) and the national procurement agency RÃkiskaup, both of which require strict CE certification, EU MDR compliance, and absolute consistency in supply volume.
Contact our export team to discuss CE-certified wound dressing solutions, product information, and distribution opportunities across Sweden, Denmark, Norway, Finland, and Iceland.
